Monitoring of steroid-induced side-effects in a severe asthma service

G. Jones (Ellesmere Port, United Kingdom)

Source: International Congress 2017 – Asthma management
Session: Asthma management
Session type: Thematic Poster
Number: 3969
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Jones (Ellesmere Port, United Kingdom). Monitoring of steroid-induced side-effects in a severe asthma service. 3969

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Assessing severe asthma
Source: Eur Respir J 2016; 48: 611-613
Year: 2016


The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003


Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016


Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Oral corticosteroids-related comorbidities in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021

Management of severe and difficult-to-treat asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013


Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands
Source: Annual Congress 2007 - Epidemiology of asthma
Year: 2007


The management of mild asthma
Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020
Year: 2021



Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021



Severe allergic asthma in routine outpatient care
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009